Immunosuppressive treatment in combination with exercise is recommended for patients with myositis to reduce disease activity and improve muscle performance. Subgrouping of patients into clinical and serological subtypes may be a way to identify biomarkers for response to specific immunosuppressive and biological agents and should be considered in future trials.
Keyphrases
- resistance training
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- rheumatoid arthritis patients
- ankylosing spondylitis
- juvenile idiopathic arthritis
- prognostic factors
- patient reported outcomes
- replacement therapy